Charles Schwab’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.8M | Buy |
296,262
+82,278
| +38% | +$6.89M | ﹤0.01% | 1550 |
|
|
2025
Q1 | $15.3M | Sell |
213,984
-3,566
| -2% | -$255K | ﹤0.01% | 1760 |
|
|
2024
Q4 | $9.78M | Buy |
217,550
+24,953
| +13% | +$1.12M | ﹤0.01% | 2022 |
|
|
2024
Q3 | $9.72M | Buy |
192,597
+130,080
| +208% | +$6.57M | ﹤0.01% | 2035 |
|
|
2024
Q2 | $2.55M | Buy |
62,517
+55,322
| +769% | +$2.26M | ﹤0.01% | 2617 |
|
|
2024
Q1 | $308K | Hold |
7,195
| – | – | ﹤0.01% | 3169 |
|
|
2023
Q4 | $290K | Buy |
+7,195
| New | +$290K | ﹤0.01% | 3226 |
|
|
2021
Q2 | – | Sell |
-8,233
| Closed | -$156K | – | 3528 |
|
|
2021
Q1 | $156K | Sell |
8,233
-2,296
| -22% | -$43.5K | ﹤0.01% | 3345 |
|
|
2020
Q4 | $305K | Hold |
10,529
| – | – | ﹤0.01% | 3155 |
|
|
2020
Q3 | $397K | Buy |
10,529
+5,725
| +119% | +$216K | ﹤0.01% | 2946 |
|
|
2020
Q2 | $160K | Buy |
+4,804
| New | +$160K | ﹤0.01% | 3196 |
|